Order Article Reprints

Kim S-Y, You BH, Bae M, Han SY, Jung K, Choi YH. Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice. Pharmaceutics. 2023; 15(9):2277. https://doi.org/10.3390/pharmaceutics15092277

Kim, Seo-Yeon, Byung Hoon You, Mingoo Bae, Seung Yon Han, Kiwon Jung, and Young Hee Choi. 2023. "Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice" Pharmaceutics 15, no. 9: 2277. https://doi.org/10.3390/pharmaceutics15092277

Kim, S.-Y., You, B. H., Bae, M., Han, S. Y., Jung, K., & Choi, Y. H. (2023). Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice. Pharmaceutics, 15(9), 2277. https://doi.org/10.3390/pharmaceutics15092277